About LoneStar Heart
LoneStar Heart was a Healthcare company based in Laguna Hills (United States) founded in 2010. It develops cardiac therapies for patients with chronic heart failure. It operates on a B2B model. LoneStar Heart has raised $45.18 million across 6 funding rounds. The company has 2 employees. LoneStar Heart has completed 1 acquisition, including CardioPolymers. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiac Therapies and Heart Failure Treatment. Its legal entity is LONESTAR HEART, INC. Its competitors include CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
LoneStar Heart develops cardiac therapies for patients with chronic heart failure through providing healthcare solutions, developing medical devices, cardiac therapies, and heart failure treatment. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Laguna Hills, United States
- Employees 2
- SectorsHealthcare
- Website lonestarheartinc.com
- Legal Name Lonestar Heart, Inc.
- Total Equity Funding$45.18M (USD)
in 6 rounds
- Latest Funding Round$4.18M (USD), Series C
Mar 2017
- Employee Count2
- Investments & Acquisitions
Funding Insights of LoneStar Heart
LoneStar Heart has successfully raised a total of $45.18M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $4.18 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45.18M
- Total Rounds 6
- Last Round Series C — $4.18M
- First Round $10.15M
(Jun 2010)
All 6 funding rounds of LoneStar Heart with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $4.18M | Series C | – | – | – |
| Sep 2014 | $1M | Series C | – | – | – |
| Nov 2013 | $2.4M | Series C | – | – | – |
| Oct 2012 | $20M | Series B | – | – | – |
| Oct 2011 | $7.45M | Series A | – | – | – |
| Jun 2010 | $10.15M | Series A | – | – | – |
Investments & Acquisitions by LoneStar Heart
LoneStar Heart has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CardioPolymers.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biopolymer implant therapies are developed to treat cardiac abnormalities. | cardiopolymers.com | Laguna Hills, United States | 2003 | Jun 2010 | •••• |
Complete acquisition details for LoneStar Heart
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LoneStar Heart
4 dated milestones of LoneStar Heart across 7 years, from founding to its latest funding, stage changes and deals.
- Founded LoneStar Heart is founded.
- Acquisition Acquires CardioPolymers.
- Funding First funding round of $10.2M.
- Funding Latest funding round, Series C, of $4.2M.
Competitors of LoneStar Heart
LoneStar Heart has 10 listed competitors in our database, 10 of them funded. They include CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| sequanamedical.com | 2006 | Zurich, Switzerland | $35.5M | – | Implantable battery-powered pumps for ascites removal are developed. | |
| adonamed.com | 2017 | Campbell, United States | $71M | – | Medical devices for heart failure management are developed. | |
| elementscience.com | 2013 | San Francisco, United States | $192.6M | – | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. | |
| vwavemedical.com | 2009 | Caesarea, Israel | $128M | – | Implantable inter-atrial shunts are developed to treat chronic heart failure. | |
| ancoraheart.com | 2001 | San Francisco, United States | $151.26M | 89 | Minimally invasive ventriculoplasty system for heart failure and FMR | |
| augmenix.com | 2008 | Waltham, United States | $46.6M | 153 | Hydrogel spacers are provided for prostate cancer radiation therapy. | |
| bioventrix.com | 2003 | San Ramon, United States | $181.42M | 20 | Ventricular reconstruction devices for heart failure are developed. | |
| amacathera.ca | 2015 | Toronto, Canada | $14.22M | – | Injectable hydrogel platform developed for therapeutic medical applications. | |
| syncardia.com | 2001 | Tucson, United States | $60.96M | – | Total artificial hearts are developed for cardiac replacement therapy. |
Detailed competitors of LoneStar Heart
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as LoneStar Heart (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lonestar Heart
Complete news archive for LoneStar Heart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LoneStar Heart
LoneStar Heart was founded in 2010.
LoneStar Heart is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
LoneStar Heart is a funded company, having raised a total of $45.18M across 6 funding rounds to date. The company's 1st funding round was a Series A of $10.15M, raised on Jun 2010.
LoneStar Heart has 2 employees.
LoneStar Heart develops cardiac therapies for patients with chronic heart failure through providing healthcare solutions, developing medical devices, cardiac therapies, and heart failure treatment. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
LoneStar Heart's top competitors include Sequana Medical, CVRx and Adona Medical.
LoneStar Heart has made 1 acquisition, including CardioPolymers.
LoneStar Heart operates through Lonestar Heart, Inc..